Jbs NV · Q2 2026 earnings

Briefing

JBS N.V. reported record net sales of $23.9 billion for Q2 2026, up 14% year-over-year, with a net loss of $102 million.

JBS N.V. delivered record quarterly revenue driven by strength across its multi-protein and multi-geography platform. Profitability declined year-over-year due to tough comparisons in poultry and non-recurring items, resulting in a net loss, though adjusted EPS was $0.20 and free cash flow turned positive. The company returned $1 billion in dividends and maintained strong liquidity.

• Net sales reached a record $23.9 billion, up 14% YoY.
• IFRS adjusted EBITDA fell 18% to $1.429 billion; adjusted EPS was $0.20.
• Reported net loss of $102 million due to non-recurring costs including bond tenders and antitrust settlements.
• Free cash flow improved to positive $130 million; net leverage at 3.1x with $7.7 billion liquidity.

Headline financials

No explicit numerical guidance provided; focus on operational efficiency, plant optimizations, and value-added growth.